MALLINCKRODT
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.
MALLINCKRODT
Social Links:
Industry:
Biotechnology
Founded:
1867-01-01
Address:
Blanchardstown, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.mallinckrodt.com
Total Employee:
5001+
Status:
Active
Contact:
+1 314-654-2000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Current Advisors List
David Carlucci Member of Board of Directors @ Mallinckrodt Board_member
Melvin Booth Chairman of the Board of Directors @ Mallinckrodt Board_member
Current Employees Featured
Ryan Magee
Ryan Magee Global Device Engineering Director of Validation and Engineering Services @ Mallinckrodt Global Device Engineering Director of Validation and Engineering Services 2019-07-01
Jim Shortt
Jim Shortt Engineering Manager @ Mallinckrodt Engineering Manager 2016-07-01
Emil Mallinckrodt
Emil Mallinckrodt Founder @ Mallinckrodt Founder
Mark Trudeau
Mark Trudeau CEO @ Mallinckrodt CEO
Matt Harbaugh
Matt Harbaugh CFO @ Mallinckrodt CFO
Oliver Fay
Oliver Fay Project Manager, ARD Program Management @ Mallinckrodt Project Manager, ARD Program Management
Founder
Emil Mallinckrodt
Stock Details
Company's stock symbol is NYSE:MNK
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-12-26 | Sucampo Pharmaceuticals | Sucampo Pharmaceuticals acquired by Mallinckrodt | 1.2 B USD |
2017-11-02 | Ocera Therapeutics | Ocera Therapeutics acquired by Mallinckrodt | 42 M USD |
2017-08-04 | InfaCare Pharmaceutical | InfaCare Pharmaceutical acquired by Mallinckrodt | N/A |
2016-08-10 | Stratatech Corporation | Stratatech Corporation acquired by Mallinckrodt | N/A |
2015-08-10 | Therakos | Therakos acquired by Mallinckrodt | 1.33 B USD |
2015-03-05 | Ikaria | Ikaria acquired by Mallinckrodt | 2.3 B USD |
2014-04-07 | Questcor Pharmaceuticals | Questcor Pharmaceuticals acquired by Mallinckrodt | N/A |
2014-02-11 | Cadence Pharmaceuticals | Cadence Pharmaceuticals acquired by Mallinckrodt | N/A |
2012-09-24 | CNS Therapeutics (Old) | CNS Therapeutics (Old) acquired by Mallinckrodt | 100 M USD |
1997-07-24 | Nellcor Puritan Bennett | Nellcor Puritan Bennett acquired by Mallinckrodt | 1.81 B USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-07-18 | Silence Therapeutics | Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics | 5 M USD |
Newest Events participated
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Official Site Inspections
http://www.mallinckrodt.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.69 K
- Host name: 45.60.250.79
- IP address: 45.60.250.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...